WHY IT MATTERS: If state health authorities move forward with potency restrictions or new labeling requirements, patients who rely on higher-concentration products for legitimate medical purposes may face reduced access or need to significantly adjust their dosing strategies. CLINICAL OVERVIEW: Public health officials are raising concerns about the increasing potency of cannabis products available in the legal market, particularly regarding exposure among adolescents and young people. The discussion centers on how THC concentrations in modern products differ substantially from those in cannabis consumed decades ago, and what that means for developing brains.
The Week in Weed: February 27, 2026 – Lexology
WHY IT MATTERS: Patients starting cannabis therapy should understand that acute effects, including changes in perception, heart rate, and cognition, are time-limited but real, and knowing what to expect helps reduce anxiety and supports safer, more informed use. CLINICAL OVERVIEW: Research from the University of Calgary and Washington State University has added to the growing body of evidence examining how cannabis affects the body acutely, with findings pointing to measurable physiological and psychoactive responses following cannabis use. Understanding acute cannabis effects is clinically relevant because these short-term changes inform how patients should be counseled around timing, setting, and dose when initiating or adjusting therapy.